Cargando…
A microarray-based system for the simultaneous analysis of single nucleotide polymorphisms in human genes involved in the metabolism of anti-malarial drugs
BACKGROUND: In order to provide a cost-effective tool to analyse pharmacogenetic markers in malaria treatment, DNA microarray technology was compared with sequencing of polymerase chain reaction (PCR) fragments to detect single nucleotide polymorphisms (SNPs) in a larger number of samples. METHODS:...
Autores principales: | Hodel, Eva Maria, Ley, Serej D, Qi, Weihong, Ariey, Frédéric, Genton, Blaise, Beck, Hans-Peter |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2797017/ https://www.ncbi.nlm.nih.gov/pubmed/20003204 http://dx.doi.org/10.1186/1475-2875-8-285 |
Ejemplares similares
-
FlexiChip package: an universal microarray with a dedicated analysis software for high-thoughput SNPs detection linked to anti-malarial drug resistance
por: Steenkeste, Nicolas, et al.
Publicado: (2009) -
Population pharmacokinetics of mefloquine, piperaquine and artemether-lumefantrine in Cambodian and Tanzanian malaria patients
por: Staehli Hodel, Eva Maria, et al.
Publicado: (2013) -
Pharmacological considerations in the design of anti-malarial drug combination therapies – is matching half-lives enough?
por: Hastings, Ian M, et al.
Publicado: (2014) -
Plasmodium falciparum resistance to anti-malarial drugs in Papua New Guinea: evaluation of a community-based approach for the molecular monitoring of resistance
por: Marfurt, Jutta, et al.
Publicado: (2010) -
Adherence to and acceptability of artemether-lumefantrine as first-line anti-malarial treatment: evidence from a rural community in Tanzania
por: Kabanywanyi, Abdunoor M, et al.
Publicado: (2010)